期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 409, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jns.2019.116603
关键词
Multiple sclerosis; Ocrelizumab; Late onset absolute neutropenia; Treatment naive; Monoclonal antibody treatment; Anti-CD20